Filter Results:
(333)
Show Results For
- All HBS Web (333)
- Faculty Publications (142)
Show Results For
- All HBS Web (333)
- Faculty Publications (142)
- 01 Jun 2018
- News
The Long Run
trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
president and CEO of Cytokinetics, Inc., a California-based company that focuses on biology-driven treatments for amyotrophic lateral sclerosis (ALS) and other debilitating diseases associated with muscle weakness. In 2015, the ALS... View Details
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- Web
HBS Magazine - Alumni
Career-Retirement Psychology-Behavior Career-Career Changes After Ozempic How a game-changing drug is reshaping Novo Nordisk, disrupting the pharma industry, and setting up a once-in-a-generation windfall for philanthropy View Story... View Details
- 01 Mar 2008
- News
The Last Frontier
state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was... View Details
- 01 Sep 2004
- News
A Market-Based Prescription
and nephrologist. In a focused factory, all these resources are integrated. These diabetic specialists jointly develop treatment protocols and pricing. Together, they offer a full range of services customized for this disease. Research... View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
Cytokinetics, Inc., a South San Francisco–based company that focuses on treatments for debilitating diseases that compromise muscle function, such as amyotrophic lateral sclerosis (ALS), heart failure, and spinal muscular atrophy.... View Details
Keywords: Deborah Blagg
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's... View Details
Keywords: Julia Hanna
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
interrelated. People who have studied this industry for a long time have come up with a number of feasible ideas to get at the cost problem, including high-deductible insurance and health savings accounts. But until we make sure that the View Details
- Profile
Arjun Goyal
a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical development... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 01 Jun 2012
- News
The Power of Philanthropy
announced its approval of Kalydeco, a drug produced by Vertex that will immediately help some 1,200 cystic fibrosis patients and is viewed as a breakthrough precursor drug to forthcoming products that will... View Details
- Web
Kraft Accelerator
data-driven innovations are disrupting drug discovery. But we must learn how to use these emerging technologies better so that we can ask more sophisticated questions, and come up with deeper insights into biology and the understanding... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
health information network are expected to be substantial. A RAND Corporation study estimates savings to the U.S. health-care system of up to $162 billion a year by improving medical-care delivery, reducing medical errors and adverse drug... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells... View Details
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes Dan Morrell: In 2008, Jim Langford (MBA 1984) became the executive director of the Georgia Meth Project, a nonprofit that blanketed his native state with a graphic, disturbing ad campaign dedicated to... View Details